NCT04841811 2023-11-18
APPROACH
Guangdong Association of Clinical Trials
Phase 3 Recruiting
Clinical Trials
6 trialsNCT06043973 2023-09-21
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
Qianfoshan Hospital
Phase 3 Recruiting
NCT05800223 2023-04-05
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
Shanghai Cancer Hospital, China
Phase 3 Recruiting
NCT05768490 2023-03-14
Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases
Sun Yat-sen University
Phase 3 Recruiting
NCT04500704 2020-08-05
ACROSS1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Unknown
NCT04500717 2020-08-05
ACROSS2
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Unknown